| Product Code: ETC12012291 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The import shipments of drugs for schistosomiasis in Mauritius saw a notable shift in concentration levels from high to moderate in 2024, indicating a more balanced distribution among top exporting countries. Despite a slight decline in growth rate from 2023 to 2024, the compound annual growth rate (CAGR) over the period of 2020-2024 remained positive at 4.71%. Key exporting countries such as India, Metropolitan France, Germany, Turkey, and the UK continue to play significant roles in supplying these essential medications to Mauritius, highlighting the importance of international partnerships in combating schistosomiasis.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mauritius Drugs for Schistosomiasis Market Overview |
3.1 Mauritius Country Macro Economic Indicators |
3.2 Mauritius Drugs for Schistosomiasis Market Revenues & Volume, 2022 & 2032F |
3.3 Mauritius Drugs for Schistosomiasis Market - Industry Life Cycle |
3.4 Mauritius Drugs for Schistosomiasis Market - Porter's Five Forces |
3.5 Mauritius Drugs for Schistosomiasis Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
3.6 Mauritius Drugs for Schistosomiasis Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
3.7 Mauritius Drugs for Schistosomiasis Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Mauritius Drugs for Schistosomiasis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Mauritius Drugs for Schistosomiasis Market Trends |
6 Mauritius Drugs for Schistosomiasis Market, By Types |
6.1 Mauritius Drugs for Schistosomiasis Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Mauritius Drugs for Schistosomiasis Market Revenues & Volume, By Drug Type, 2022 - 2032F |
6.1.3 Mauritius Drugs for Schistosomiasis Market Revenues & Volume, By Praziquantel, 2022 - 2032F |
6.1.4 Mauritius Drugs for Schistosomiasis Market Revenues & Volume, By Oxamniquine, 2022 - 2032F |
6.1.5 Mauritius Drugs for Schistosomiasis Market Revenues & Volume, By Metrifonate, 2022 - 2032F |
6.1.6 Mauritius Drugs for Schistosomiasis Market Revenues & Volume, By Artesunate, 2022 - 2032F |
6.2 Mauritius Drugs for Schistosomiasis Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Mauritius Drugs for Schistosomiasis Market Revenues & Volume, By Hospital Pharmacies, 2022 - 2032F |
6.2.3 Mauritius Drugs for Schistosomiasis Market Revenues & Volume, By Retail Pharmacies, 2022 - 2032F |
6.2.4 Mauritius Drugs for Schistosomiasis Market Revenues & Volume, By Online Pharmacies, 2022 - 2032F |
6.2.5 Mauritius Drugs for Schistosomiasis Market Revenues & Volume, By Government Programs, 2022 - 2032F |
6.3 Mauritius Drugs for Schistosomiasis Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Mauritius Drugs for Schistosomiasis Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.3.3 Mauritius Drugs for Schistosomiasis Market Revenues & Volume, By Research Institutes, 2022 - 2032F |
6.3.4 Mauritius Drugs for Schistosomiasis Market Revenues & Volume, By Public Health Organizations, 2022 - 2032F |
6.3.5 Mauritius Drugs for Schistosomiasis Market Revenues & Volume, By Clinics, 2022 - 2032F |
7 Mauritius Drugs for Schistosomiasis Market Import-Export Trade Statistics |
7.1 Mauritius Drugs for Schistosomiasis Market Export to Major Countries |
7.2 Mauritius Drugs for Schistosomiasis Market Imports from Major Countries |
8 Mauritius Drugs for Schistosomiasis Market Key Performance Indicators |
9 Mauritius Drugs for Schistosomiasis Market - Opportunity Assessment |
9.1 Mauritius Drugs for Schistosomiasis Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
9.2 Mauritius Drugs for Schistosomiasis Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
9.3 Mauritius Drugs for Schistosomiasis Market Opportunity Assessment, By End User, 2022 & 2032F |
10 Mauritius Drugs for Schistosomiasis Market - Competitive Landscape |
10.1 Mauritius Drugs for Schistosomiasis Market Revenue Share, By Companies, 2025 |
10.2 Mauritius Drugs for Schistosomiasis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here